Chromatin Expulsion by the DNA Replication Licensing Factor ORC4 during Asymmetric Cell Division in Meiosis and Differentiation
减数分裂和分化过程中不对称细胞分裂过程中 DNA 复制许可因子 ORC4 的染色质排出
基本信息
- 批准号:10059254
- 负责人:
- 金额:$ 31.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-01-01 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsAntibodiesAssisted Reproductive TechnologyAttentionBehaviorBindingBiologyCell CycleCell divisionCellsCellular StressChimeric ProteinsChromatinChromosomesComplexCritiquesCytokinesisDNADNA Replication TimingDNA biosynthesisDataDevelopmentDevelopmental BiologyElementsEmbryoEnvironmentErythroblastsErythrocytesEukaryotaEventExonsFemaleFertilizationFutureGenesGenomeGoalsHaploidyHawaiiHumanIn VitroInfertilityInjectionsKnock-in MouseKnockout MiceLeadLicensing FactorLoxP-flanked alleleMeiosisMinorModelingMolecularMusNamesORC1L geneOocytesOogenesisPatternPeptidesPlayPrincipal InvestigatorProcessProductivityProteinsPublicationsPublishingReagentReplication LicensingReplication OriginReportingReproductionResearchResourcesRoleSiteSmall Interfering RNATestingTransgenic MiceUniversitiesVariantVesicleWorkcell typeexperimental studyimmunocytochemistryinnovationinsightmouse modelmutantoocyte maturationorigin recognition complexoverexpressionpolymerizationpreventprotein complexrecruitresponsesegregationtrafficking
项目摘要
The goal of studies described in this amended R01 application is to explore the role of the DNA licensing factor, ORC4, in sequestering chromosomes into polar bodies via cage formation during female meiosis. These studies were considered highly innovative and with fundamental significance for understanding the mechanism of female meiotic division and oocyte maturation, as well as other possible forms of asymmetric cell division. Other strengths of the application include the outstanding qualifications and record of productivity of the Principal Investigator, the recruitment of a strong collaborative team with complementary expertise, the highly conducive research environment at the University of Hawaii, the convincing premise in the form of previous publications and preliminary data confirming the underlying functionalities of ORC4, the availability of many key reagents and resources required to pursue the project goals, adequate attention to elements of scientific rigor and a strong response to the previous critiques. In addition to these abundant strengths, some expressed concerns with an underdeveloped approach, including lack of guidance as to the mechanistic implications for experiments involving ORC4 depletion, beyond previous observations, concerns that overexpression of the EGFP-ORC-4 fusion protein may induce cell stress or lethality, lack of feasibility of purification of ORC4 interacting partners and the absence of sufficient insight on the role of ORC4 in other forms of asymmetric cell division. While these and other minor weaknesses slightly reduced the perceived merit of the application, the panel ultimately concluded that the very high novelty and fundamental mechanistic insights to be gained will exert a major impact on the fields of oocyte development and developmental biology.
rtility.
在这个修订的R01申请中描述的研究目的是探索DNA许可因子ORC4在雌性减数分裂期间通过笼形形成将染色体隔离到极体中的作用。这些研究被认为是极具创新性的,对理解雌性减数分裂和卵母细胞成熟的机制以及其他可能的不对称细胞分裂形式具有重要意义。该申请的其他优势包括首席研究员的杰出资格和生产力记录,招募了一个具有互补专业知识的强大合作团队,夏威夷大学非常有利的研究环境,以前出版物形式的令人信服的前提和初步数据确认ORC4的潜在功能。实现项目目标所需的许多关键试剂和资源的可用性,对科学严谨性要素的充分关注以及对先前批评的强烈回应。除了这些丰富的优势之外,一些人对不发达的方法表示担忧,包括缺乏对涉及ORC4消耗的实验的机制影响的指导,超出先前的观察,担心EGFP-ORC-4融合蛋白的过度表达可能诱导细胞应激或致死,ORC4相互作用伙伴的纯化缺乏可行性,以及对ORC4在其他形式的不对称细胞分裂中的作用缺乏足够的了解。虽然这些和其他一些小的缺点略微降低了应用程序的优点,但专家组最终得出结论,认为将获得的非常高的新颖性和基本机制见解将对卵母细胞发育和发育生物学领域产生重大影响。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Functional Aspects of Sperm Chromatin Organization.
- DOI:10.1007/978-3-031-06573-6_10
- 发表时间:2022-01-01
- 期刊:
- 影响因子:0
- 作者:Ribas-Maynou, Jordi;Nguyen, Hieu;Ward, W Steven
- 通讯作者:Ward, W Steven
ArfGAP1 inhibits mTORC1 lysosomal localization and activation.
- DOI:10.15252/embj.2020106412
- 发表时间:2021-06-15
- 期刊:
- 影响因子:0
- 作者:Meng D;Yang Q;Melick CH;Park BC;Hsieh TS;Curukovic A;Jeong MH;Zhang J;James NG;Jewell JL
- 通讯作者:Jewell JL
The role of ORC4 in enucleation of Murine Erythroleukemia (MEL) cells is similar to that in oocyte polar body extrusion.
- DOI:10.1080/19396368.2020.1822458
- 发表时间:2020-12
- 期刊:
- 影响因子:2.4
- 作者:Nguyen H;Ung A;Ward WS
- 通讯作者:Ward WS
AKAP13 couples GPCR signaling to mTORC1 inhibition.
- DOI:10.1371/journal.pgen.1009832
- 发表时间:2021-10
- 期刊:
- 影响因子:4.5
- 作者:Zhang S;Wang H;Melick CH;Jeong MH;Curukovic A;Tiwary S;Lama-Sherpa TD;Meng D;Servage KA;James NG;Jewell JL
- 通讯作者:Jewell JL
Low levels of mouse sperm chromatin fragmentation delay embryo development.
- DOI:10.1093/biolre/ioad106
- 发表时间:2023-11-15
- 期刊:
- 影响因子:3.6
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM S WARD其他文献
WILLIAM S WARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM S WARD', 18)}}的其他基金
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 31.84万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 31.84万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 31.84万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 31.84万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 31.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 31.84万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 31.84万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 31.84万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 31.84万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 31.84万 - 项目类别: